Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
36
CXXI.CX Quote, Financials, Valuation and Earnings
Last price:
$0.44
Seasonality move
:
20.84%
Day range:
$0.44 - $0.51
52-week range:
$0.15 - $0.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.13x
P/B ratio:
1.36x
Volume:
134.7K
Avg. volume:
85.9K
1-year change:
54.39%
Market cap:
$51.9M
Revenue:
$41.9M
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, C21 Investments, Inc. has -- downside to fair value with a price target of -- per share.
CXXI.CX vs. S&P 500
-
Over the past 5 trading days, C21 Investments, Inc. has underperformed the S&P 500 by -21.51% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
C21 Investments, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
C21 Investments, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter C21 Investments, Inc. reported revenues of $11.7M.
Earnings Growth
-
C21 Investments, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter C21 Investments, Inc. reported earnings per share of -$0.01.
Enterprise value:
63.8M
EV / Invested capital:
--
Price / LTM sales:
1.13x
EV / EBIT:
15.97x
EV / Revenue:
1.38x
PEG ratio (5yr expected):
-4.88x
EV / Free cash flow:
23.94x
Price / Operating cash flow:
19.64x
Enterprise value / EBITDA:
8.42x
Gross Profit (TTM):
$17.4M
Return On Assets:
-5.02%
Net Income Margin (TTM):
-8.7%
Return On Equity:
-9.95%
Return On Invested Capital:
-6.88%
Operating Margin:
14.5%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | $37.5M | $46.2M | $10.2M | $11.7M | |
| Gross Profit | -- | $12.9M | $17.4M | $3.7M | $5.3M | |
| Operating Income | -- | -$94.6K | $4M | $213.8K | $1.7M | |
| EBITDA | -- | $4M | $7.6M | $1.4M | $2.5M | |
| Diluted EPS | -- | -$0.05 | -$0.04 | -$0.01 | -$0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $10.8M | $12.4M | |
| Total Assets | -- | -- | -- | $79.1M | $78.1M | |
| Current Liabilities | -- | -- | -- | $22.8M | $10M | |
| Total Liabilities | -- | -- | -- | $38.3M | $40.1M | |
| Total Equity | -- | -- | -- | $40.8M | $38M | |
| Total Debt | -- | -- | -- | $16.6M | $14.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$46.1K | $3.1M | -$1.3M | $592.7K | |
| Cash From Investing | -- | -$5.3M | $603.3K | -$74.5K | $21K | |
| Cash From Financing | -- | $3.9M | -$2.7M | -$21.9K | -$433K | |
| Free Cash Flow | -- | -$5.4M | $2.7M | -$1.4M | $579.2K | |
CXXI.CX
Sector
Market Cap
$51.9M
$27.9M
Price % of 52-Week High
64.71%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
7.36%
-1.49%
1-Year Price Total Return
54.39%
-16.66%
Beta (5-Year)
2.056
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.51
200-day SMA
Buy
Level
$0.35
Bollinger Bands (100)
Sell
Level
0.39 - 0.57
Chaikin Money Flow
Sell
Level
-4M
20-day SMA
Sell
Level
$0.45
Relative Strength Index (RSI14)
Sell
Level
47.92
ADX Line
Buy
Level
18.71
Williams %R
Neutral
Level
-70.5882
50-day SMA
Sell
Level
$0.48
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
13.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.9182)
Buy
CA Score
(Annual)
Level (-0.0987)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.2703)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
C21 Investments, Inc. engages in the cannabis business. It operates through the Nevada and Corporate geographical segments. It also focuses on the cultivation, processing, and distribution of cannabis and hemp-derived consumer products in the United States. The firm owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers and oil, pre-rolls, vaporizer cartridges and edibles. The company was founded on January 15, 1987 and is headquartered in Vancouver, Canada.
Stock Forecast FAQ
In the current month, CXXI.CX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CXXI.CX average analyst price target in the past 3 months is --.
-
Where Will C21 Investments, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that C21 Investments, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About C21 Investments, Inc.?
Analysts are divided on their view about C21 Investments, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that C21 Investments, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is C21 Investments, Inc.'s Price Target?
The price target for C21 Investments, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CXXI.CX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for C21 Investments, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CXXI.CX?
You can purchase shares of C21 Investments, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase C21 Investments, Inc. shares.
-
What Is The C21 Investments, Inc. Share Price Today?
C21 Investments, Inc. was last trading at $0.44 per share. This represents the most recent stock quote for C21 Investments, Inc.. Yesterday, C21 Investments, Inc. closed at $0.44 per share.
-
How To Buy C21 Investments, Inc. Stock Online?
In order to purchase C21 Investments, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CXXI.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CXXI.CX
Sector
P/E ratio
--
23.85x
PEG ratio
-4.88x
-0.01x
P/B ratio
1.36x
1.81x
Price / LTM sales
1.13x
1.58x
Growth Metrics
CXXI.CX
Sector
Revenue growth
13.91%
4.62%
Earnings growth
40.63%
10.5%
Revenue (5-year growth)
-3.46%
6.5%
Earnings forecast
--
-$0.21
Profitability
CXXI.CX
Sector
Profitability FY 2024
$14.4M
$3.6M
Return on invested capital
-6.88%
-31.87%
Return on assets
-5.02%
-28.18%
Return on equity
-9.95%
-37.63%
Earnings Date
Last Earnings Date
Dec
15
Next Earnings Date
Dec
22
Estimated Next Earnings Date
Mar
23
Balance Sheet
CXXI.CX
Sector
Total cash
$3.9M
$26.4M
Short term investments
--
$25.7M
Total assets
$83.2M
$76.9M
Long term debt
$14.9M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
